Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
5.48 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 12.62 | 13.159 | 63.458 | 16.455 | 5.154 | 114.597 | 90.055 | 134.896 | 4.105 | 12.517 |
| Short Term Investments
| 14.529 | 29.144 | 5.993 | 27.804 | 72.828 | 75.401 | 44.949 | 129.846 | 90.281 | 0 |
| Cash and Short Term Investments
| 27.149 | 42.303 | 69.451 | 44.259 | 77.982 | 114.597 | 90.055 | 134.896 | 94.386 | 12.517 |
| Net Receivables
| 0.063 | 0.633 | 0.539 | 0.086 | 0.329 | 0.337 | 0.132 | 0.365 | 0.347 | 0 |
| Inventory
| 0 | -0.735 | -0.667 | -0.492 | -0.815 | -0.602 | -0.852 | -1.137 | 0.722 | 0 |
| Other Current Assets
| 0.744 | 0.102 | 0.128 | 0.406 | 0.486 | 0.265 | 0.72 | 0.772 | 0.208 | 0.012 |
| Total Current Assets
| 27.956 | 42.303 | 69.451 | 44.259 | 77.982 | 114.597 | 90.055 | 134.896 | 95.663 | 12.529 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 1.385 | 2.217 | 3.19 | 1.648 | 2.327 | 2.18 | 2.672 | 3.248 | 1.845 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 16.123 | 21.877 | 34.266 | 37.225 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.089 | 1.843 | 2.548 | 2.397 | 3.337 | 1.455 | 2.048 | 2.006 | 0.951 | 0 |
| Total Non-Current Assets
| 17.597 | 25.937 | 40.004 | 41.27 | 5.664 | 3.635 | 4.72 | 5.254 | 2.796 | 0 |
| Total Assets
| 45.553 | 68.24 | 109.455 | 85.529 | 83.646 | 118.232 | 94.775 | 140.15 | 98.459 | 12.529 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 1.525 | 1.976 | 1.565 | 3.467 | 2.448 | 1.998 | 3.454 | 1.9 | 1.575 | 0.057 |
| Short Term Debt
| 1.374 | 2.601 | 3.647 | 2.31 | 3.188 | 0 | 0 | 0 | -0.223 | 2.6 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 6.96 | 0 | 0 | 0 | 0 | 0 | 0.223 | -2.583 |
| Other Current Liabilities
| 3.97 | 7.548 | 0.121 | 7.604 | 6.899 | 5.898 | 6.486 | 5.449 | 1.495 | 2.6 |
| Total Current Liabilities
| 6.869 | 12.125 | 12.293 | 13.381 | 12.535 | 7.896 | 9.94 | 7.349 | 3.07 | 2.674 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 0 | 1.373 | 2.601 | 1.232 | 2.31 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -2.601 | -1.232 | -2.31 | 0.869 | 0.971 | 1.405 | 126.49 | 10.014 |
| Total Non-Current Liabilities
| 0 | 1.373 | 2.601 | 1.232 | 2.31 | 0.869 | 0.971 | 1.405 | 126.49 | 10.014 |
| Total Liabilities
| 6.869 | 12.125 | 12.293 | 13.381 | 12.535 | 7.896 | 9.94 | 7.349 | 129.56 | 12.688 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140.15 | 125.78 | 10.011 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 | 0 | 0 |
| Retained Earnings
| -334.717 | -307.688 | -266.381 | -223.14 | -217.145 | -170.473 | -123.534 | -67.871 | -31.496 | -0.161 |
| Accumulated Other Comprehensive Income/Loss
| -0.967 | -0.563 | 1.869 | 0.004 | 0.029 | -0.034 | -0.041 | -0.039 | -0.045 | 0 |
| Other Total Stockholders Equity
| 374.363 | 364.361 | 361.669 | 295.281 | 288.224 | 280.84 | 208.408 | 60.559 | -125.34 | -10.009 |
| Total Shareholders Equity
| 38.684 | 56.115 | 97.162 | 72.148 | 71.111 | 110.336 | 84.835 | 132.801 | -31.101 | -0.159 |
| Total Equity
| 38.684 | 56.115 | 97.162 | 72.148 | 71.111 | 110.336 | 84.835 | 132.801 | -31.101 | -0.159 |
| Total Liabilities & Shareholders Equity
| 45.553 | 68.24 | 109.455 | 85.529 | 83.646 | 118.232 | 94.775 | 140.15 | 98.459 | 12.529 |